Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I messaged IR asking about their LSD Inhibitor and if they had intentions on selling the inhibitor to other companies who are doing R&D on psychedelics once they have their patent approved for it. Still waiting to hear back from them...Could be a nice opportunity for a non-dilutional source of capital for MindMed. It’s rare to have a small-cap biotech company with a potential source of capital other than share offerings.
Yes you are correct. It sucks!!! They need to let this trade and get the word out
MindMed Announces $10 Million Bought Deal Equity Financing to Fund University Hospital Basel Collaboration https://www.otcmarkets.com/stock/MMEDF/news?id=260991
MindMed Announces $10 Million Bought Deal Equity Financing to Fund University Hospital Basel Collaboration https://www.otcmarkets.com/stock/MMEDF/news?id=260991
My biggest problem with SHRM is they aren’t being clear on their recreational pursuits. They can’t get major institutional investors if they are in the recreational space whatsoever. This is why I like MindMed. They’ve been very clear about not pursuing any recreational uses. Listen to the webinar because O’Leary speaks about this. If SHRM can’t rely on tutes/banks for fundraising then who will they rely on??? My guess would be the shareholders, which only means more dilution to raise capital to grow.
Eight Capital Initiated Coverage PT $1.42USD/$2.00 C. See link: https://pbs.twimg.com/media/EW8sxIbX0AEhqKs?format=png&name=900x900
Link to MindMed webinar with Kevin O’Leary and JR Rahn:
Link to MindMed webinar with Kevin O’Leary and JR Rahn:
It was a live Zoom webinar that was done yesterday at 1pm. I saw that they were recording it so maybe they will post it to their investor relations page to watch. You can always email them and ask if they are going to post the recorded video
Did anyone else see it gap up to $1 this morning???? I thought I was seeing things
Mind Med Webinar w/Kevin O’Leary and JR Rahn Highlights:
- Prior to investing, O’Leary’s team extensively look into Mind Med prior to investing. One of Mr. O’Leary’s employees liked the company so much that he got a loan from O’Leary for $15 million to invest. O’Leary then went and invested more because he said “I can’t have one of my employees investing more than me”.
- Absolutely no chance of recreational involvement. O’Leary made that clear so that institutional investors will be able to invest. Their goal is to achieve FDA approval and/or FDA fast-track approval through their clinical trials.
- No chance of liquidating shareholders in order to acquire any companies.
- They have a patent on a drug that neutralizes the effects of LSD.
- They are targeting microdosing LSD towards ADHD ($16 billion dollar a year industry) and anxiety/depression. JR Rahn said he got the idea to further research the applications of LSD when he was in silicon valley and had a lot of friends with ADHD who would microdose to treat and control their symptoms.
- They are targeting the drug 18-MC (derivative of ibogaine) to treat drug addiction (primarily aimed at treating opioid addiction) and alcohol abuse disorder. The application towards the treatment of opioid abuse disorder is where JR Rahn believes they may get Fast Track FDA approval if they see results because there are very few medications right now effective at treating opioid use disorder.
Please add more if you can remember things that I left out. I was unable to listen to the entire webinar.
Mind Med Webinar w/Kevin O’Leary and JR Rahn Highlights:
- Prior to investing, O’Leary’s team extensively look into Mind Med prior to investing. One of Mr. O’Leary’s employees liked the company so much that he got a loan from O’Leary for $15 million to invest. O’Leary then went and invested more because he said “I can’t have one of my employees investing more than me”.
- Absolutely no chance of recreational involvement. O’Leary made that clear so that institutional investors will be able to invest. Their goal is to achieve FDA approval and/or FDA fast-track approval through their clinical trials.
- No chance of liquidating shareholders in order to acquire any companies.
- They have a patent on a drug that neutralizes the effects of LSD.
- They are targeting microdosing LSD towards ADHD ($16 billion dollar a year industry) and anxiety/depression. JR Rahn said he got the idea to further research the applications of LSD when he was in silicon valley and had a lot of friends with ADHD who would microdose to treat and control their symptoms.
- They are targeting the drug 18-MC (derivative of ibogaine) to treat drug addiction (primarily aimed at treating opioid addiction) and alcohol abuse disorder. The application towards the treatment of opioid abuse disorder is where JR Rahn believes they may get Fast Track FDA approval if they see results because there are very few medications right now effective at treating opioid use disorder.
Please add more to this if you remember things. I was unable to listen to the entire webinar.
LOL... All jokes aside, my comments about them owning 1million SHRM shares and 750,000 warrants is not from a press release I read. It's in their SEDAR financial statements. They originally owned 1.5 million shares but sold 500,000 (unfortunately). I cannot copy the link to the specific SEDAR report so I will just tell you how to access it.
Go to the SEDAR website (see link): https://www.sedar.com/search/search_en.htm
Then click the box"Search for Company Documents" in the middle of the page
Then on the following page type "Roadman Investments Corp"
Then on the following page you will see a column titled "Document Type". Scroll down that column till you see one labeled "MD&A-English" from March 2,2020 and click the link to that.
Read page 2 of the document about Champagion Brands.
Well this is annoying. However, they still hold 1,000,000 shares of SHRM and 750,000 warrants of SHRM exercisable at $0.15/share. That is what makes them a “shroom company”.....They should’ve known better to say anything non-FDA approved (like an oil) is a treatment for a disease.
The float is 135M shares. You are correct the outstanding share count ~287,000,000 shares. But this includes every share the company has. What’s important, is to look at the public float of shares (i.e. the shares available for us to trade). That is 135,000,000.
According to your 2nd post Public Share Float is ~135,000,000 shares. That’s great news. Much less than the OS of 287,000,000
Just do the math to figure that out: From yahoo finance moments ago—> SP is 0.3793 with Market Cap of 107.506M—> $107,506,000/$0.3793 per share= approximately 283,500,000 shares... no dilution
RMANF owns 1,000,000 shares of SHRM and 750,000 SHRM warrants (exercisable at $0.15 per share that expire 8/15/2022).
RMANF: CHECK OUT WHAT I FOUND, Pay attention to the bold: "On August 15, 2019, the Company acquired 1,500,000 units (“Champignon Unit”) of Champignon Brands Inc. (“Champignon”) for $150,000 which represented approximately 5.6% of the issued and outstanding common shares of Champignon. Each Champignon Unit consists of one common share of Champignon and one-half share purchase warrant. One full warrant is exercisable at $0.15 per share until August 15, 2022.... So they also have 750,000 warrants exercisable at $0.15 until August 15,2022 as well as the 1,000,000 shares
Roadman Investment Corp Financial Statement from 3/2/2020:
https://www.sedar.com/GetFile.do?lang=EN&docClass=5&issuerNo=00026391&issuerType=03&projectNo=03024919&docId=4676397
COPY AND PASTE THIS LINK AND THEN COMPLETE THE VERIFICATION CODE AT THE BOTTOM.
Yea I bet they are kicking themselves now for that sell, but owning 1 million shares is not bad.
I looked up RMANF’s previous financial statements. They own 1,000,000 shares of Champignon Brands Inc. They originally owned 1.5 million shares but sold 500,000 on 2/25/2020. I will try to post a picture of all their current holdings from their most recent statement. I think they are undervalued given the one holding of SHRM may be worth more than their current entire market capital if SHRM’s SP continues it’s current price action.
I don’t think they are diluting. This is a very rough calculation, but using info I got off Yahoo finance a few moments ago: Current SP was $0.4146; Current market cap at that SP was $115,077,000; Market cap divided by SP= 277,561,505 shares. Actually less than the stated OS count on OTCmarkets as of 4/3 (which is why I say it is a rough estimate).
This looks like a possible cup and handle breakout.
READ THIS POST! For those of you posting here that you missed out on SHRM when it was cheap, Roadman Investment Corp (RMANF) invested $150,000 into them on August 19th,2019. You can invest in RMANF now for very cheap (0.03 a share). Here is the original press release: https://roadmancorp.com/news/roadman-investments-completes-strategic-investment-into-champignon-brands/
I have been loading RMANF for the exact reason you just mentioned. As far as I can see, this entire sector is still untapped. If it gets the hype the pot craze did, then we are in a GREAT position right now.
Cup and handle forming here?
Road Investments Corporation (RMANF): What is everyone’s opinion about this one? They are not entirely devoted to this sector, but are starting to enter it. They certainly have an attractive share price at 0.03 right now that hasn’t started the move up yet like the other mushroom stocks. Very low volume at the moment.
In my opinion, I think it is following the market. The entire shroom sector is red. May be in for a dip that continues if the market continues to pull back due to the coronavirus concerns.
MindMed Acquires Exclusive License to Eight Clinical Trials: https://www.prnewswire.com/news-releases/mindmed-acquires-exclusive-license-to-eight-clinical-trials-of-lsd-partners-with-world-leading-psychedelic-research-laboratory-at-university-hospital-basel-301033261.html
RMANF signs definitive agreement with Psychedelic Insights https://www.google.com/amp/s/www.marketscreener.com/amp/ROADMAN-INVESTMENTS-CORP-56930926/news/Roadman-Investments-Signs-Definitive-Agreement-with-Psychedelic-Insights-Solidifying-Psychedelics-30281582/
RMANF signs definitive agreement with Psychedelic Insights https://www.google.com/amp/s/www.marketscreener.com/amp/ROADMAN-INVESTMENTS-CORP-56930926/news/Roadman-Investments-Signs-Definitive-Agreement-with-Psychedelic-Insights-Solidifying-Psychedelics-30281582/
Do we know the float here? OS may be higher than SHRM but what is the float?
Looking for 0.008s today
Keep buying. Uptrend will continue. Trading very thin.
Looking for 0.025
Let’s get some buying volume. This is ready to blow.
No trades yet today? That’s odd
Gotta love flippers. I’m holding